<DOC>
	<DOCNO>NCT00006981</DOCNO>
	<brief_summary>RATIONALE : Immunotoxins locate tumor cell kill without harm normal cell . Immunotoxin therapy may effective treatment advance cancer . PURPOSE : Phase I trial study effectiveness immunotoxins treat patient advanced cancer .</brief_summary>
	<brief_title>Immunotoxin Therapy Treating Patients With Advanced Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine maximum tolerate dose toxic effect SS1 ( dsFv ) -PE38 immunotoxin patient advanced malignancy express mesothelin . Secondary - Determine response patient treated drug . - Determine plasma pharmacokinetics drug patient . OUTLINE : This open-label , dose-escalation study . Patients receive SS1 ( dsFv ) -PE38 immunotoxin IV continuously day 1-10 . Treatment repeat every 4 week maximum 4 course absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos SS1 ( dsFv ) -PE38 immunotoxin maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 6 patient experience dose-limiting toxicity . Patients follow every 3 month . PROJECTED ACCRUAL : A total 30 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Immunotoxins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm malignancy , include one following : Malignant mesothelioma Ovarian epithelial carcinoma ( mucinous nonmucinous ) , include primary peritoneal fallopian tube carcinoma Tumors may originate bowel ( e.g. , appendiceal carcinoma ) involve ovary Ovarian cancer histology eligible provide express mesothelin Pancreatic cancer Squamous cell lung cancer Squamous cell cancer head neck Squamous cell cancer cervix Recurrent unresectable disease prior standard anticancer therapy expect prolong survival improve quality life OR unwilling receive standard anticancer therapy At least 30 % initial recurrent tumor cell positive ( least 1+ ) mesothelin immunohistochemistry Measurable evaluable disease No known CNS spinal cord involvement No clinically significant pericardial effusion PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 12 week Hematopoietic : Absolute neutrophil count least 1,000/mm^3 Platelet count least 75,000/mm^3 Hepatic : Bilirubin great upper limit normal ( ULN ) AST ALT great 2.5 time ULN Albumin least 3.0 g/dL Hepatitis B C negative Renal : Creatinine great ULN OR Creatinine great 2.0 mg/dL creatinine clearance least 50 mL/min Calcium great ULN Cardiovascular : No New York Heart Association class IIIV heart disease Pulmonary : Oxygen saturation ( SO_2 ) 92 % room air Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception HIV negative No detectable antibody SS1 ( dsFv ) PE38 No infection require parenteral antibiotic PRIOR CONCURRENT THERAPY : Biologic therapy : At least 1 week since prior hematopoietic growth factor therapy Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : At least 4 week since prior antitumor therapy recover No concurrent antitumor therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2005</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>recurrent cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>advanced malignant mesothelioma</keyword>
	<keyword>recurrent malignant mesothelioma</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>ovarian undifferentiated adenocarcinoma</keyword>
	<keyword>ovarian mixed epithelial carcinoma</keyword>
	<keyword>ovarian serous cystadenocarcinoma</keyword>
	<keyword>ovarian endometrioid adenocarcinoma</keyword>
	<keyword>ovarian clear cell cystadenocarcinoma</keyword>
	<keyword>cervical squamous cell carcinoma</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>fallopian tube cancer</keyword>
	<keyword>primary peritoneal cavity cancer</keyword>
	<keyword>ovarian carcinosarcoma</keyword>
	<keyword>Brenner tumor</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>ovarian mucinous cystadenocarcinoma</keyword>
	<keyword>borderline ovarian surface epithelial-stromal tumor</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>ovarian stromal cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>